CFM
VXRT

Catalyst Funds Management’s Vaxart VXRT Stock Holding History

Catalyst Funds Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,742
Closed -$10.9K – 715
2025
Q1 		$10.9K Buy
+26,742
New +$17.2K ﹤0.01% 445
2024
Q2 		– Sell
-14,870
Closed -$19.3K – 1640
2024
Q1 		$19.3K Buy
+14,870
New +$15.6K 0.01% 769

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Catalyst Funds Management's VXRT Position: Q2 2025 in Review

Catalyst Funds Management sold out of Vaxart (VXRT) in Q2 2025, closing a stake of 26,742 shares — an estimated $10.9K sold.

Catalyst Funds Management first reported a position in VXRT in Q1 2024 and held it in 2 quarters. The position peaked at $19.3K in Q1 2024. 98 funds tracked by Wall St. Rank hold VXRT as of Q2 2025.

  • Catalyst Funds Management reported no remaining Vaxart position as of Q2 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 26,742 Vaxart shares in Q2 2025, an estimated $10.9K.
  • Catalyst Funds Management first reported a position in Vaxart in Q1 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Vaxart position peaked at $19.3K in Q1 2024.
  • 98 funds tracked by Wall St. Rank held Vaxart as of Q2 2025.

Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.